Renowned Pioneers in Ophthalmology Join SparingVision’s Scientific Advisory Board
Development of lead asset SPVN06 to further benefit from high-level Clinical Advisory Board Paris, January…
New investors include 4BIO Capital, UPMC Enterprises, Jeito Capital and Ysios Capital with additional investment…
Paris, June 30th, 2020 – SparingVision, a biotechnology company specializing in the research and development…